Clinical trial
The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in…
NCT00002371 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00002371 |
|---|---|
| Title | The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine |
| Official title | A Randomized Double-Blind Study of Safety, Virologic and Immunological Effects of Stavudine Plus Lamivudine (3TC) Versus Zidovudine Plus Lamivudine in HIV-Infected Subjects Following At Least Six Months of Zidovudine Therapy |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Indinavir sulfate, Lamivudine, Stavudine, Zidovudine |
| Enrollment | 80 |
| Start date | Jun 1, 1996 |
| Primary completion | Dec 1, 1997 |
| Completion | Dec 1, 1997 |
| First posted | Aug 31, 2001 |
| Last update posted | May 4, 2011 |
| Countries | Canada, Puerto Rico, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: